Pfizer reports over 25% fall in Q3 net profit

Pfizer Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 500680 | NSE: PFIZER

01 Feb 2014 Evaluate

Pfizer has reported results for third quarter ended December 31, 2013.

The company has reported 25.48% fall in its net profit at Rs 47.60 crore for the quarter as compared to Rs 63.88 crore for the same quarter in the previous year. However, total income from operations of the company has increased by 6.17% at Rs 272.19 crore for quarter under review, as compared to Rs 256.35 crore for the quarter ended December 31, 2012.

Pfizer Inc is the parent company of Pfizer, which manufactures prescription drugs such as Viagra, Lyrica, Viagra, Dolonex Gel, Ponstan, Citralka Liquid, and many more.

Peers

Company Name	CMP
Sun Pharma. Inds.	1850.80
Dr. Reddys Labs.	1216.60
Cipla	1382.10
Lupin	2101.00
Zydus Lifesciences	1171.95
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.